These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33128033)
1. Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT). Lee NE; Kim SH; Yu DY; Woo EJ; Kim MI; Seong GS; Lee SM; Ko JH; Kim YS Commun Biol; 2020 Oct; 3(1):636. PubMed ID: 33128033 [TBL] [Abstract][Full Text] [Related]
2. Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies. Yoon HW; Jo M; Ko S; Kwon HS; Lim CS; Ko BJ; Lee JC; Jung ST Mol Immunol; 2019 Oct; 114():62-71. PubMed ID: 31336250 [TBL] [Abstract][Full Text] [Related]
3. Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAs. Chen TF; Sazinsky SL; Houde D; DiLillo DJ; Bird J; Li KK; Cheng GT; Qiu H; Engen JR; Ravetch JV; Wittrup KD J Mol Biol; 2017 Aug; 429(16):2528-2541. PubMed ID: 28694069 [TBL] [Abstract][Full Text] [Related]
4. Development of an immunoassay for aglycosylated murine IgG1 in mouse serum via generation of a specific tool antibody. Poon-Andersen C; Dhoolypala H; Wong D; Soto M; Salimi-Moosavi H; Chan B; Kielczewska A; Cook KD Bioanalysis; 2022 May; 14(9):581-588. PubMed ID: 35548877 [No Abstract] [Full Text] [Related]
11. Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance. Jo M; Kwon HS; Lee KH; Lee JC; Jung ST MAbs; 2018; 10(2):278-289. PubMed ID: 29173039 [TBL] [Abstract][Full Text] [Related]
12. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. Tao MH; Morrison SL J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634 [TBL] [Abstract][Full Text] [Related]
13. Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant. Hand PH; Calvo B; Milenic D; Yokota T; Finch M; Snoy P; Garmestani K; Gansow O; Schlom J; Kashmiri SV Cancer Immunol Immunother; 1992; 35(3):165-74. PubMed ID: 1638552 [TBL] [Abstract][Full Text] [Related]
14. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Walker MR; Lund J; Thompson KM; Jefferis R Biochem J; 1989 Apr; 259(2):347-53. PubMed ID: 2524188 [TBL] [Abstract][Full Text] [Related]
15. Glycan profiling of proteins using lectin binding by Surface Plasmon Resonance. Wang W; Soriano B; Chen Q Anal Biochem; 2017 Dec; 538():53-63. PubMed ID: 28947169 [TBL] [Abstract][Full Text] [Related]
16. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Chargelegue D; Vine ND; van Dolleweerd CJ; Drake PM; Ma JK Transgenic Res; 2000 Jun; 9(3):187-94. PubMed ID: 11032367 [TBL] [Abstract][Full Text] [Related]
17. Development of on-chip fully automated immunoassay system "μTASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma. Kurosawa T; Watanabe M Proteomics; 2016 Dec; 16(24):3056-3061. PubMed ID: 27272472 [TBL] [Abstract][Full Text] [Related]
19. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. Martin RM; Brady JL; Lew AM J Immunol Methods; 1998 Mar; 212(2):187-92. PubMed ID: 9672206 [TBL] [Abstract][Full Text] [Related]
20. Development of glycan specific lectin based immunoassay for detection of prostate specific antigen. Bhanushali PB; Badgujar SB; Tripathi MM; Gupta S; Murthy V; Krishnasastry MV; Puri CP Int J Biol Macromol; 2016 May; 86():468-80. PubMed ID: 26840176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]